en
Scientific article
English

Homocysteine metabolism is associated with cerebrospinal fluid levels of soluble amyloid precursor protein and amyloid beta

Published inJournal of Neurochemistry, vol. 139, no. 2, p. 324-332
Publication date2016
Abstract

Disturbed homocysteine metabolism may contribute to amyloidogenesis by modulating the amyloid precursor protein (APP) production and processing. The objective of this study was to investigate the relationships between cerebral amyloid production and both blood and cerebrospinal fluid (CSF) markers of the homocysteine metabolism. We assessed CSF concentrations of soluble APPα, soluble APPβ, and amyloid β1-42 (Aβ1-42), as well as plasma levels of homocysteine (Hcys), total vitamin B12, and folate, and CSF concentrations of homocysteine (Hcys-CSF), 5-methyltetrahydrofolate (5-MTHF), S-adenosylmethionine (SAM), and S-adenosylhomocysteine (SAH) in 59 subjects with normal cognition. Linear regression analyses were performed to assess associations between homocysteine metabolism parameters and amyloid production. The study was approved by the Ethical Committee of the University of Bonn. After controlling for age, gender, APOEe4 status, and albumin ratio (Qalb), higher Aβ1-42 CSF levels were associated with high Hcys and low vitamin B12 plasma levels as well as with high Hcys, high SAH, and low 5-MTHF CSF levels. Higher CSF concentrations of sAPPα and sAPPβ were associated with high SAH levels. The results suggest that disturbed homocysteine metabolism is related to increased CSF levels of sAPP forms and Aβ1-42, and may contribute to the accumulation of amyloid pathology in the brain. Disturbed homocysteine metabolism may contribute to amyloidogenesis by modulating the amyloid precursor protein (APP) production and processing. We found associations between CSF levels of soluble APP forms and Aβ1-42, and markers of the homocysteine metabolism in both plasma and CSF in adults with normal cognition. Disturbed homocysteine metabolism may represent a target for preventive and early disease-modifying interventions in Alzheimer's disease.

Keywords
  • Adult
  • Albumins/metabolism
  • Amyloid beta-Peptides/cerebrospinal fluid
  • Amyloid beta-Protein Precursor/cerebrospinal fluid
  • Apolipoprotein E4/genetics
  • Female
  • Folic Acid/cerebrospinal fluid
  • Healthy Volunteers
  • Homocysteine/blood/cerebrospinal fluid/metabolism
  • Humans
  • Male
  • Middle Aged
  • Neuropsychological Tests
  • Peptide Fragments/cerebrospinal fluid
  • Reference Values
  • S-Adenosylmethionine/cerebrospinal fluid
  • Tetrahydrofolates/cerebrospinal fluid
  • Vitamin B 12/cerebrospinal fluid
Affiliation Not a UNIGE publication
Citation (ISO format)
OIKONOMIDI, Aikaterini et al. Homocysteine metabolism is associated with cerebrospinal fluid levels of soluble amyloid precursor protein and amyloid beta. In: Journal of Neurochemistry, 2016, vol. 139, n° 2, p. 324–332. doi: 10.1111/jnc.13766
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal0022-3042
362views
0downloads

Technical informations

Creation06/08/2018 9:48:00 AM
First validation06/08/2018 9:48:00 AM
Update time03/15/2023 8:22:34 AM
Status update03/15/2023 8:22:33 AM
Last indexation01/17/2024 3:06:34 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack